» Authors » Rachael L Cohen

Rachael L Cohen

Explore the profile of Rachael L Cohen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 56
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cohen R, Drewes J, Queen S, Freeman Z, Pate K, Adams R, et al.
Comp Med . 2021 Nov; 71(6):466-473. PMID: 34794530
Macaques with self-injurious behavior (SIB) have been used as a model of human SIB and have previously been shown to respond to treatments targeting enhancement of central serotonin signaling, whether...
2.
Cohen R, Margolis R
Curr Opin Neurol . 2016 Nov; 29(6):735-742. PMID: 27748686
Purpose Of Review: Spinocerebellar ataxia type 12 (SCA12) is a rare autosomal dominant neurodegenerative disease characterized by tremor, gait abnormalities, and neuropsychiatric syndromes. The location of the causative CAG/CTG expansion...
3.
OHearn E, Hwang H, Holmes S, Rudnicki D, Chung D, Seixas A, et al.
Mov Disord . 2015 Sep; 30(13):1813-1824. PMID: 26340331
Objective: SCA12 is a progressive autosomal-dominant disorder, caused by a CAG/CTG repeat expansion in PPP2R2B on chromosome 5q32, and characterized by tremor, gait ataxia, hyperreflexia, dysmetria, abnormal eye movements, anxiety,...
4.
DeClue A, Sharp C, Cohen R, Leverenz E, Reinero C
J Feline Med Surg . 2010 Aug; 12(10):754-9. PMID: 20719552
This study evaluated the effects of a cysteinyl-leukotriene-1 (cys-LT(1)) receptor antagonist, zarfirlukast, during feline endotoxemia. Six adult, sexually intact male cats received either placebo or zarfirlukast (10mg, PO) and endotoxin...
5.
KuKanich B, Cohen R
Vet J . 2009 Oct; 187(1):133-5. PMID: 19854080
The purpose of this study was to assess the pharmacokinetics of gabapentin in healthy greyhound dogs after single oral doses targeted at 10 and 20mg/kg PO. Six healthy greyhounds were...
6.
Cohn L, DeClue A, Cohen R, Reinero C
J Feline Med Surg . 2009 Aug; 12(2):91-6. PMID: 19647461
Cats with inflammatory bronchial disease are usually treated with glucocorticoid (GC) drugs to reduce airway inflammation. Inhalant GC delivery can preserve airway effects while systemic effects are minimized. An appropriate...